Stocks / AHCO vs LXRX

AdaptHealth Corp. (AHCO) vs Lexicon Pharmaceuticals, Inc. (LXRX)

AdaptHealth Corp. and Lexicon Pharmaceuticals, Inc. side by side — fundamentals from SEC filings, refreshed nightly. Sector: Healthcare.

AHCO is the larger company ($1.4B vs $0.8B). On the fundamentals, AHCO grows revenue faster (25.2% vs 15.7%); AHCO earns a higher net margin (-2.2% vs -101.1%); AHCO has the stronger return on equity (-4.7% vs -46.8%). Over the last five years, LXRX returned -59.0% vs -63.6%. On the filings, AHCO carries fewer potential red flags (1 vs 3). Full numbers below — the stronger figure on each row is in green.

AI verdict — AHCO vs LXRX, read from the filings

The stronger business, the cheaper stock, and the risks — synthesised from both companies’ SEC filings, every figure computed not guessed. Not investment advice.

 AdaptHealth Corp. (AHCO)Lexicon Pharmaceuticals, Inc. (LXRX)
Market cap$1.4B$0.8B
Revenue (latest FY)$3.24B$49.80M
Net income (latest FY)$-70.79M$-50.34M
Revenue growth (5y CAGR)25.2%15.7%
Net margin-2.2%-101.1%
Return on equity-4.7%-46.8%
P/E ratio
Dividend yield
Profitable years (of last 10)41
Positive free cash flowYesNo

Performance — AHCO vs LXRX

Total returns from monthly split- and dividend-adjusted closes; 52-week range from the latest quote. Past performance is not a prediction.

 AdaptHealth Corp. (AHCO)Lexicon Pharmaceuticals, Inc. (LXRX)
1-year return5.7%97.9%
3-year return-18.1%-17.9%
5-year return-63.6%-59.0%
10-year return-86.9%
52-week range$8.06–$13.43$0.64–$2.53

Verify the comparison

Use the filing period and source shown by each tool before treating two figures as comparable.

Compare with another company:

See the full AHCO vs LXRX breakdown

Both companies across 19 years of income statement, balance sheet and cash flow — with ratios, health checks and Ask, the SEC-grounded research assistant. Free, no account needed.

Open AHCO's full financials →   Open LXRX's full financials →

More comparisons

Frequently asked questions

Which is bigger, AHCO or LXRX?

AdaptHealth Corp. is larger by market capitalization — $1.4B versus $0.8B.

Which grows faster, AHCO or LXRX?

Over the last five fiscal years, AdaptHealth Corp. grew revenue faster — 25.2%/yr versus 15.7%/yr, computed from SEC-filed statements.

Where does this data come from?

All figures are computed from official SEC filings (10-K), refreshed nightly. This is a data comparison, not investment advice.

Keep exploring

AHCO fundamentals → · LXRX fundamentals → · All 1,500+ companies → · Free screener →